Skip to main content
Livermore
Livermore
ZHEN

TSFG, LLC

SEC CIK
0001800513
Latest filing
Jul 23, 2026

TAK holding history

Takeda Pharmaceutical Co Ltd in every 13F filed by TSFG, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

TAK overviewAll 13F holders of TAKFull Q2 2026 holdings

Shares (Q2 2026)
7,796
Value
$125.0K
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of TAK by TSFG, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20267,796$125.0K<0.1%+192+2.5%AddedHolders
Q1 20267,604$141.0K<0.1%−135−1.7%ReducedHolders
Q4 20257,739$121.0K<0.1%−8,373−52.0%ReducedHolders
Q3 202516,112$236.0K<0.1%+93+0.6%AddedHolders
Q2 202516,019$248.0K<0.1%−6,529−29.0%ReducedHolders
Q1 202522,548$335.0K0.1%−2,278−9.2%ReducedHolders
Q4 202424,826$329.0K0.1%−324−1.3%ReducedHolders
Q3 202425,150$358.0K0.1%−489−1.9%ReducedHolders
Q2 202425,639$332.0K0.1%+1,965+8.3%AddedHolders
Q1 202423,674$329.0K0.1%−1,072−4.3%ReducedHolders
Q4 202324,746$353.0K0.1%−3,369−12.0%ReducedHolders
Q3 202328,115$435.0K0.2%−9,532−25.3%ReducedHolders
Q2 202337,647$591.0K0.2%−588−1.5%ReducedHolders
Q1 202338,235$630.0K0.2%+665+1.8%AddedHolders
Q4 202237,570$586.0K0.2%−125−0.3%ReducedHolders
Q3 202237,695$489.0K0.2%+2,458+7.0%AddedHolders
Q2 202235,237$495.0K0.2%00.0%UnchangedHolders
Q1 202235,237$505.0K0.2%−4,036−10.3%ReducedHolders
Q4 202139,273$535.0K0.2%−1,371−3.4%ReducedHolders
Q3 202140,644$666.0K0.3%−2,963−6.8%ReducedHolders
Q2 202143,607$734.0K0.3%−1,237−2.8%ReducedHolders
Q1 202144,844$819.0K0.4%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.